To understand the compromised survival of embryos derived from assisted reproductive techniques, transcriptome survey of early embryonic development has shown the impact of in vitro culture environment on gene expression in bovine or other living species. However, how the differentially expressed genes translate into developmentally compromised embryos is unresolved. We therefore aimed to characterize transcriptomic markers expressed by bovine blastocysts cultured in conditions that are known to impair embryo development. As increasing glucose concentrations has been shown to be stressful for early cleavage stages of mammalian embryos and to decrease subsequent blastocyst survival, in vitro-matured/fertilized bovine zygotes were cultured in control (0.2 mM) or high-glucose (5 mM) conditions until the 8-to 16-cell stage, and then transferred to control media until they reached the blastocyst stage. The concentration of 5 mM glucose was chosen as a stress treatment because there was a significant effect on blastocyst rate without the treatment's being lethal as with 10 mM. Microarray analysis revealed gene expression differences unrelated to embryo sex or hatching. Overrepresented processes among differentially expressed genes in treated blastocysts were extracellular matrix signalling, calcium signaling, and energy metabolism. On a pathophysiological level, higher glucose treatment impacts pathways associated with diabetes and tumorigenesis through genes controlling the Warburg effect, i.e., emphasis on use of anaerobic glycolysis rather than oxidative phosphorylation. These results allowed us to conclude that disruption of in vitro preattachment development is concomitant with gene expression modifications involved in metabolic control.
INTRODUCTION
For more than 30 years, assisted reproductive techniques (ART) have been established in different mammalian species and widely used around the world. However, concerns regarding the impact of embryo manipulation on the health of the offspring have been reported, notably in livestock [1] . In cattle, the negative impact of in vitro production (IVP) results in an estimated 30% of offspring suffering from abnormally high birth weight (large offspring syndrome), which creates the need for frequent cesarean sections. Furthermore, IVP is also associated with increased gestation length, skewing of the male:female ratio (higher proportion of males) [2] , and a higher frequency of congenital malformations and perinatal mortality. It is estimated that one third of in vitro-derived conceptuses are lost during the first month of gestation [1] .
In investigating the cause of the short-and long-term impacts of ART, some teams have hypothesized that the in vitro environment is partly responsible. In vivo, the embryos develop in an undefined, complex environment and exhibit a dynamic metabolism, i.e., slow metabolism during early cleavage stages followed by activation to support proliferation and differentiation during blastulation. Therefore, subjecting the early embryo to an in vitro culture (IVC) condition, inappropriate to its metabolism, may be partly responsible for embryonic stress and deviations from the normal phenotype [3] [4] [5] .
Although some changes in IVC protocols have been made to improve embryo development in ART, no valuable tools are available to assess the stress-related impact resulting from IVC. In this context, the current challenge is to define markers indicative of embryonic stress during development of IVC embryos [6] in order to formulate appropriate culture conditions to improve viability and the success of ART.
A promising solution for developing stress markers is to study the gene expression profile of cultured embryos [7] . During early cleavage, transcription is inactivated and development is supported by continued synthesis of proteins from mRNA stored during oocyte maturation [8] . Once this RNA support is degraded after successive cleavages of the zygote, mechanisms regulating the nucleus state will allow embryonic cells to activate gene transcription, a phenomenon called embryonic genome activation (EGA) [9] . This critical event (8-to 16-cell stage in cow) allows the maternal-embryo transition and transcriptional control of embryonic development [10] . Recent studies have shown that the environmental milieu per se has an important influence on gene expression in produced bovine blastocysts [11] . Meanwhile, transcriptomic variations in IVC embryos compared to their in vivo counterparts have been proposed to reflect embryonic quality [12] , but direct mechanistic links between differential gene expression and IVC-induced embryonic stress are still lacking.
Therefore, the aim of this study is to analyze the development and gene expression of preattachment bovine embryos following IVC in the stress condition of hyperglycemia. Indeed, numerous studies have shown that excessive glucose exposure results in a decreased-viability phenotype in early embryo development. High glucose during early cleavage stages has been correlated with developmental block at the time of EGA and low quality of blastocysts [13] [14] [15] . Moreover, hyperglycemia induces developmental delay of preimplantation development [16] . During early cleavage stages, the embryo utilizes low amounts of glucose, and pyruvate, lactate, and glutamine are the preferred substrates for its metabolism [17] . In bovine oviductal fluid, glucose concentration is lower (2 mM) than in blood serum (4 mM), indicating a differential regulation in the secretion of this energy substrate by the oviduct epithelium in order to match embryo metabolism [18] .
Experimentally, in vitro-produced bovine zygotes were cultured with increasing glucose concentration during early cleavages (8-to 16-cell stage) and transferred to control media until reaching the blastocyst stage. Embryo survival was determined by assessing the development rate of 8-to 16-cell embryos (at Day 3), then blastocyst and hatched blastocyst embryos (at Day 7). Large-scale analysis of gene expression was performed in the blastocyst stage by microarray slides that were specifically enriched in genes expressed during bovine preattachment development [19] . Functional analysis tools were used to highlight the expressed genes and molecular pathways significantly perturbed in hyperglycemia-treated blastocysts.
MATERIALS AND METHODS
All chemicals were obtained from Sigma-Aldrich unless otherwise stated.
IVP of Bovine Blastocysts
Oocyte collection and in vitro maturation. Cumulus-oocyte complexes (COCs) were obtained by aspirating follicles from the ovaries of slaughtered heifers. After four washes in HEPES-buffered Tyrode lactate solution (TLH), groups of up to 10 selected COCs with at least five layers of cumulus were placed in 50-ll drops of medium under mineral oil in dishes (Nunc) and maturated for 24 h at 398C under an atmosphere of 5% CO 2 in air with maximum humidity. The maturation medium was TCM-199 supplemented with 10% fetal calf serum (HyClone; ThermoScientific), 0.1 lg/ml of folliclestimulating hormone (Folltropin V; Bioniche), 0.33 mM of pyruvic acid, and 50 lg/ml of gentamycin.
In vitro fertilization. Following maturation, five matured COCs were added to 48-ll droplets of in vitro fertilization (IVF) medium under mineral oil. The IVF medium was composed of stock Tyrode lactate solution supplemented with 0.6% fatty acid-free bovine serum albumin (BSA), 0.2 mM pyruvic acid, 10 lg/ ml heparin, and 50 lg/ml gentamycin. Prior to transfer, the COCs were washed twice in TLH medium. Once transferred, 2 ll of PHE (1 mM hypotaurine, 2 mM penicillamine, 250 mM epinephrine) was added to each droplet 10 min before spermatozoa was added. The spermatozoa used consisted of a cryopreserved mixture of ejaculates from five bulls (Centre d'Insémination Artificielle du Québec, St.-Hyacinthe, QC). The spermatozoa were thawed in 378C water for 1 min, put on a discontinuous Percoll gradient (2 ml of 45% Percoll over 2 ml of 90% Percoll), and centrifuged at 700 3 g for 30 min at 268C. After the supernatant was discarded, the pellet of live spermatozoa was resuspended in IVF medium after being counted on a hemocytometer to obtain a concentration of 10 6 cells/ml. Finally, 2 ll of the sperm suspension (final concentration ¼ 4.10 4 cells/ml) was added to each IVF droplet containing the matured COC, and the incubation took place in a humidified atmosphere at 38.58C in 5% CO 2 for 16-18 h.
In vitro culture. For embryo culture, a three-step modified synthetic oviduct fluid culture system containing minimum essential medium, essential and nonessential amino acids, 0.5 mM glycyl-glutamine, and 0.4% fatty acid-free BSA under embryo-tested mineral oil (#8410, Sigma) was used. The embryo culture dishes were incubated at 38.58C with 6.5% CO 2 , 5% O 2 , and 88.5% N 2 in 100% humidity. Briefly, after fertilization, presumptive zygotes were mechanically denuded and washed three times in TLH supplemented with fatty acid-free BSA and were placed in groups of 10 in 10-ll droplets of synthetic oviduct fluid 1 (SOF1) with nonessential amino acids (13) and 3 lM EDTA. Embryos were transferred in new 10-ll droplets of SOF2 containing nonessential (13) and essential (0.53) amino acids 72 h postfertilization and once again 120 h postfertilization in 20-ll droplets of SOF3 containing nonessential (13) and essential (13) amino acids. Media were replaced three times to prevent toxicity due to ammonium accumulation and nutrient depletion caused respectively by amino acid degradation and embryo metabolism. The glucose concentrations used in SOF1, SOF2, and SOF3 were respectively 0.2, 0.5, and 1.0 mM. Blastocyst development was assessed at Day 7 postfertilization. Pooled blastocysts (hatched and nonhatched) were transferred, washed three times in PBS, collected in groups of 10 in small volumes of PBS into 0.5-ml microtubes, and stored at À808C until RNA extraction. Cleavage rate (number of embryos with at least two cells out of total embryos) and 8-to 16-cell embryo rate (number of embryos with at least eight cells out of total embryos) were determined during embryo transfer from SOF1 to SOF2 (Day 3). Blastocyst rate (number of early, expanded, and hatched blastocysts out of total embryos) and hatching rate (number of hatched blastocysts out of total blastocysts) were calculated at the end of the culture.
Determination of Hyperglycemic Treatment
Glucose dose-response experiment. The glucose dose response-experiment was performed by adding increasing amounts of glucose (0.2 [control concentration], 1, 2, 5, or 10 mM) in SOF1 during the first 3 days of embryo development after fertilization. Total embryos were then transferred to normal culture conditions until reaching the blastocyst stage. At least three replicates (20-30 presumptive zygotes per replicate) were done for each glucose concentration except for the lethal concentration of 10 mM (one replicate). Increasing the glucose concentration up to 10 mM (10 mOsm) did not significantly affect the osmolarity of culture medium (300 mOsm). Because this was a preliminary experiment, results were not subjected to statistical analysis.
Production of control and high-glucose-treated blastocysts. As 5 mM of glucose in SOF1 appeared to be the limit dose for blastocyst development, we selected this criterion as hyperglycemic treatment to produce seven replicates of control and high-glucose-treated blastocysts from different IVP runs. Each replicate contained around 10 embryos, including not-expanded (early), expanded, and hatched blastocysts. Although increased glucose treatment decreased the hatching rate, equivalent proportions of hatched blastocysts were distributed between control and treatment replicates. Four out of seven replicates were used for the microarray experiment, and three out of seven replicates were used to validate the microarray results by qRT-PCR. Unpaired t-tests were used for statistical comparison of developmental rate between control and 5 mM glucose treatment.
Determination of Differential Gene Expression in Treated Blastocysts
Total RNA from each replicate was extracted and purified using the PicoPure RNA Isolation Kit (Life Science). After DNase digestion (Qiagen), quality and concentration of extracted RNA was analyzed by bioanalyzer (Agilent). All extracted samples showed good quality with an RNA integrity number .7.5.
For microarray purposes, purified RNA was amplified by in vitro transcription by T7 RNA amplification using the RiboAmp HS Plus RNA Amplification Kit (Life Science) and labeled with Cy3 and Cy5 using the ULS Fluorescent Labeling Kit (Kreatech), and antisense RNA (825 ng per replicate) was hybridized on the Agilent-manufactured EmbryoGENE slides [19] in a two-color dye-swap design. After 17 h of hybridization at 658C, microarray slides were washed for 1 min in gene Expression Wash Buffer 1 (room temperature), 3 min in gene Expression Wash Buffer 2 (428C), 10 sec in 100% acetonitrile (room temperature) and 30 sec in Stabilization and Drying Solution (Agilent). Slides were scanned with PowerScanner (Tecan) and features extraction was done with Array-pro6.3 (MediaCybernetics). Intensity files were analyzed with FlexArray 1.6.1 (Michal Blazejczyk, Mathieu Miron, Robert Nadon (2007), FlexArray: A statistical data analysis software for gene expression microarrays. Genome Quebec, Montreal, Canada, URL: http:// genomequebec.mcgill.ca/FlexArray).
Specifically, raw data were corrected by background subtraction, then normalized within and between each array (Loess and quantile, respectively). Stastistical comparison between treatments (hyperglycemia vs. control) was done with the Limma algorithm. Significant differences between treatments were determined with a P value less than 0.05.
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE33008 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE33008).
Validation of microarray results was done by RT-quantitative PCR (qPCR). Total extracted RNA from independent samples (three replicates for each condition) was reverse transcribed using oligo-dT primer and qScript Flex cDNA Synthesis Kit (Quanta Biosciences). Specific primers for each selected gene were designed using PrimerQuest (Integrated DNA Technologies) and qPCR was performed using LightCycler 480 SYBR Green I Master and the CAGNONE ET AL.
LightCycler 480 System (Roche). A standard curve constituted of five points of the PCR product for each primer pair diluted from 1 pg to 0.1 fg was used for real-time quantification of PCR output. Data normalization used GeNORM normalization factor [20] from expression values of three reference genes (ACTB, CHUK, B2M). Moreover, technical variations were assessed and corrected through quantification of exogenous GFP spike, which was introduced at the time of RNA extraction [8] . Primer sequences, product size, annealing temperature, and accession numbers are provided in Supplemental Table S3 .
Functional Analysis of Differential Gene Expression Profile in Treated Blastocysts
DAVID software was used to group overrepresented functions of differentially expressed genes into clusters [21, 22] . Moreover, data were analyzed through the use of Ingenuity Pathways Analysis (IPA; Ingenuity Systems, www.ingenuity.com), which served to compile canonical pathways as well as gene product interactions (networks) that were differentially expressed between treatments. We used IPA to build schematic representations of important pathways deregulated in treated blastocysts.
Network Generation. A data set containing gene identifiers and corresponding expression values was uploaded into the application. Each identifier was mapped to its corresponding object in Ingenuity's Knowledge Base. A fold-change cutoff of 1.5 with a P value ,0.05 was set to identify molecules whose expression was significantly differentially regulated. These molecules, called network-eligible molecules, were overlaid onto a global molecular network developed from information contained in Ingenuity's Knowledge Base. Networks of network-eligible molecules were then algorithmically generated based on their connectivity. Molecules are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). All edges are supported by at least one reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Pathways Knowledge Base. Human, mouse, and rat orthologs of a gene are stored as separate objects in the Ingenuity Pathways Knowledge Base, but are represented as a single node in the network. Nodes are displayed using various shapes that represent the functional class of the gene product.
Canonical pathway analysis. Canonical pathway analysis identified the pathways from the IPA library of canonical pathways that were most significant to the data set. The significance of the association between the data set and the canonical pathway was measured in two ways: 1) a ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway was displayed; 2) Fisher exact test was used to calculate a P value to determine the probability that the association between the genes in the dataset and the canonical pathway would occur by chance alone. Green and red symbols represented genes respectively down-and up-regulated in treated embryos compared to controls. Gray symbols represented genes with significant expression in blastocysts but no difference between conditions, whereas white symbols represented genes not present on microarray or with below-background intensity.
RESULTS

Five Micromolar Glucose Is a Critical Dose for the Preattachment Development of In Vitro-Produced Bovine Embryos
In order to clearly characterize the impact of hyperglycemia on embryo development, IVP zygotes were exposed to increasing glucose doses until reaching the limit of embryonic plasticity. Different glucose concentrations were used (0.2
[control], 1, 2, 5, and 10 mM) during the early cleavage stages of development (until the 8-to 16-cell stage), then all embryos were cultured in control media until reaching the blastocyst stage. Our preliminary results showed that adding 1-5 mM of glucose did not affect the developmental rate of IVC 8-16 cells (please see Supplemental Table S1 ; all Supplemental Data are available online at www.biolreprod.org). However, a 10 mM concentration of glucose decreased the rate of embryos reaching the 8-to 16-cell stage and prevented blastocyst development. Therefore, the increased glucose dose of 5 mM was used to produce more replicates of treated and control blastocysts. In regard to preliminary results, statistical comparison between control and 5 mM glucose-treated embryos showed a significant decrease in the blastocyst rate and hatching rate after high glucose treatment ( Table 1) . The small discrepancy with the preliminary results could be explained by the larger sample size of cultured embryos and the overall higher rate of blastocyst development. Nonetheless, these results indicated that early exposure to 5 mM glucose was detrimental for subsequent survival of bovine embryos.
Exposure to 5 mM Glucose During Early Cleavage Stages Impacts Subsequent Gene Expression at Blastocyst Stage
Microarray experiments. Large-scale transcriptomic comparison between control and 5 mM glucose-treated embryos at 1 . Number of expressed genes in control or treated blastocysts as well as differentially expressed between these two conditions. In control and treatment conditions, embryonic gene expression was assessed through microarray technology. Results indicate the number of probes with an intensity signal higher than the summation of background intensity and two times its SD for each condition (green and brown). Moreover, overlapping with significantly differential expressed genes between conditions (violet) is represented (superior to 1.5-fold change, P , 0.05). 
HYPERGLYCEMIA AND EARLY EMBRYONIC GENE EXPRESSION
the blastocyst stage was done through microarray analysis. The microarray design covers the majority of the bovine preattachment transcriptome that allows analyzing most forms of gene expression in bovine blastocysts [19] . Out of 37 238 targeted gene transcripts represented on the microarray slide, 22 681 and 22 886 had a signal higher than the summation of background intensity plus two times the SD of background, indicating the presence of the mRNA for these genes in control and highglucose-treated blastocysts respectively (Fig. 1) . Statistical analysis of microarray comparisons revealed a significantly different expression (P , 0.05) for 490 transcript sequences, and 63 had more than 1.5 fold-change differences between control and treated blastocysts (please see Supplemental Table  S2 ). Moreover, among these 63 sequences, 57 were upregulated in treated blastocysts. Functional analysis. Sex-related genes: In order to determine if the differentially expressed genes were associated with skewing of the sex ratio in 5 mM glucose-treated blastocysts, the proportion of genes that could be related to embryonic sex was analyzed [23] . Among hyperglycemia-related genes found in bovine blastocysts, only 6.2% showed a moderate (fold change .1.5, P value ,0.05) overlap with sex-related genes (clusterin, myeloid/lymphoid, or mixed-lineage leukemia [trithorax homolog. drosophila] translocated to 11, SERPINE1, thrombospondin 1).
Stage-related genes: Even if a similar proportion of hatched blastocyst from each pool of control and treatment were used in the microarray comparison, the proportion of genes that could be related to blastocyst stage (young, expanded, hatched) was analyzed in order to discard potential bias linked to embryonic developmental speed [24] . Among hyperglycemia-related genes found in bovine blastocysts, only one gene (collagen triple helix repeat containing 1) showed a moderate overlap with stage-related genes (fold change .1.5, P value ,0.05). If several of the stage-specific targeted genes had been associated with the treatment, it could have indicated a stage effect in addition to a treatment effect.
Cellular and molecular functions: DAVID software significantly clustered molecular functions of extracellular matrix remodeling as well as cell adhesion. These functions were associated with cell motility, defense/response to external wounding/stimulus, and calcium management. Using IPA, the canonical pathways with significant value were high-mobility group box 1 (HMGB1) signaling; integrin-linked kinase (ILK) signaling; hypoxia inducible factor 1, alpha subunit basic helixloop-helix transcription factor (HIF1A) signaling; transforming growth factor beta (TGF-B) signaling; oxidative stress response; tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) signaling; tight junction signaling; interferon signaling; glutathione metabolism; and peroxisome proliferator-activated receptor alpha (PPARA) signaling. Ingenuitygenerated networks reflected processes of tissue development, metabolic disease. and tumor morphology. Figure 2A shows the canonical pathway of HMGB1 signaling. Figure 2B shows the regulation network of HIF1A signaling pathway.
Reverse transcription-qPCR. A total of 17 selected genes from microarray and functional analysis (ADAMTS1, ASCL2,  C1QTNF3, EDN3, GPX8, HIF1A, HTRA1, IGFBP7, JAM2,  LDHA, PPARG, SERPINE1, TGM2, TKTL1, TNFRSF1A,  TP53BP2 , and VIM) were quantified in three independent biological replicates from control and treated groups by RTqPCR ( Fig. 3 ; for gene names please see Supplemental Table  S3 ). Results showed positive validation of differential expression for 82% of selected genes (59% [10/17] with P , 0.05, and 24% [4/17] with 90% confidence interval). Among selected candidates, relative expression differences (fold change) from microarray and RT-qPCR experiments were significantly correlated (R ¼ 0.69, P , 0.0001). When looking only at the selected genes that exhibited a positive 1.5-fold change in the microarray comparison, differential expression was validated by RT-qPCR for 100% of them (6/10 with P , 0.05 and 4/10 with P , 0.1). Overall, these validations allow confident interpretation of results obtained by array hybridization and statistical/functional analysis.
DISCUSSION
Transcriptomic analysis is useful to understand the impact of IVC on embryo development, but gene expression profiles associated with metabolic stress need characterization. Therefore, this study investigated the impact of exposure to metabolic stress during IVC on gene expression modifications in IVP bovine blastocysts. Hyperglycemia during early cleavage stages was selected as the stress condition because it has been shown to be detrimental for early zygote divisions and subsequent blastocyst survival.
In our preliminary dose-response experiment, bovine zygote exposure to 10 mM glucose prevented blastocyst development due to cleavage arrest during progression to the 8-to 16-cell stage. This observation is in agreement with previous publications that have shown that increased glucose concentration in the medium blocks early cleavage development [16, 25] . This developmental block reflects a phenomenon known as the Crabtree effect, whereby high intracellular glucose stimulates glycolysis that perturbs oxidative phosphorylation (OX-PHOS) by altering mitochondrial metabolism [14, [25] [26] [27] [28] . When 5 mM glucose was used, early cleavage bovine zygotes exhibited developmental plasticity, as seen by the ability to reach 8-16 cells. However, after the embryos were transferred into normal culture conditions, subsequent development to the blastocyst stage and hatching was decreased. These findings are consistent with other studies in hamster and cow that have shown that postcompaction development is compromised when cleavage-stage embryos are exposed to mild hyperglycemia (1.5-5 mM) [13, 27] .
The molecular mechanisms underlying developmental impairment of blastocysts after early hyperglycemic treatment (5 mM) are not clearly understood but are likely to result from nonblocking perturbations induced by the Crabtree effect during cleavage stages [27] . Transcriptomic analysis revealed that high-glucose-treated blastocysts showed, in association [29, 30] and may reflect perturbed development [12] . When looking at the ratio of up-and down-regulated genes in treated blastocysts, almost all are overexpressed. Gene overexpression is characteristic of in vitro produced embryos compared to their in vivo counterparts and could be associated with active, unquiet metabolism [31] . Thus, major up-regulation of gene expression in treated blastocysts would reflect a disruption of metabolic quietness. The study of differential mRNA level needs cautious interpretation, as the correspondence with the protein level has not been demonstrated. Here, functional analysis of differentially expressed genes showed strong similarity with gene expression in hyperglycemia-associated diabetes. In diabetes, hyperglycemia increases intracellular glucose and results in its conversion to sorbitol by aldose reductase and concomitant decrease in NADPH (polyol pathway). Hyperglycemic induction of the polyol pathway has deleterious effects because of NADPH depletion that is required to reduce glutathione and protect cells from reactive oxygen species (ROS; H 2 O 2 ) [32] . The 5 mM glucose-treated blastocysts showed increased expression of GPX8 (glutathione peroxidase 8), a member of the antioxidant enzyme family involved in the reduction of H 2 O 2 into water by oxidation of glutathione. GPX expression is highly correlated with increased aldose reductase activity in the pathology of diabetes [33] . Moreover, embryos cultured with high glucose show increased sorbitol production and a delay in blastocyst stage development [16] . As GPX and glutathione play a major antioxidant role during preimplantation embryonic development [34, 35] , GPX8 expression suggests the activation of oxidative stress response likely due to NADPH depletion through polyol pathway activation in treated blastocysts.
HYPERGLYCEMIA AND EARLY EMBRYONIC GENE
Diabetic hyperglycemia leads to production of advanced glycation end products (AGE) that modify the expression of extracellular matrix (ECM) proteins [36] . Our data show an increased expression of lumican and decorin, ECM proteoglycans that are targeted by AGE modification and up-regulated in diabetic kidney [37, 38] . High-glucose-treated blastocysts upregulate JAM2, a junction adhesion molecule that may be associated with angiogenesis in metabolic alterations of diabetes mellitus [39] . Finally, AGE modifications disrupt receptor binding and result in the expression of genes coding for a cytokine (TGF-B) and a proinflammatory molecule (PLAT) [36, 40] that are both up-regulated in treated blastocysts and suggest a critical role for AGE production in the impact of hyperglycemia on early embryo development. These matrix-related responses like those in somatic tissues either indicate that the blastocyst is reacting as a somatic cell or hypothetically indicate a dysregulation by expressing genes that are normally quite silent in blastocysts. As AGE production is negatively correlated with reproductive health [41] [42] [43] [44] ; AGE-associated gene expression may be valuable markers of lower survival rate observed in treated blastocyst.
Activation of the hexosamine pathway is a hallmark of hyperglycemia in diabetes. Because of fructose-6-P diversion from the glycolytic pathway, concomitant accumulation of glucosamine-6-P induces protein glycosylation of transcription factor Sp1, which activates SERPINE 1 and THBS1 expression and contributes to the pathogenesis of diabetic complications [36, [45] [46] [47] [48] [49] . During murine preimplantation development, hexosamine pathway activation and O-linked glycosylation mediate the embryotoxic effect of hyperglycemia [50] . Upregulation of THBS1 and SERPINE1 in treated blastocysts suggests the increased activity of hexosamine pathway and could be a marker of developmentally compromised embryos. In addition, THBS1 expression is regulated through activation of aryl hydrocarbon receptor (AHR) in endothelial cells exposed to high glucose [51] .
Diabetes-associated hyperglycemia also affects protein kinase C (PKC) signaling. We observed an up-regulation of S100A11, a gene coding for a Ca 2þ -binding protein, in highglucose-treated blastocysts. S100 members are secreted proteins that are dependent on parallel activation of PKC as well as elevation of intracellular calcium concentrations [52] , and their expression is up-regulated by hyperglycemia [53] . Moreover, phosphorylation of S100A11 by PKC likely occurs through interaction with AGE receptor signaling [54] . Treated blastocysts showed up-regulation of SCG2 (secretogranine II), a gene coding for a secreted protein whose expression is controlled by calcium influx and PKC activation in bovine medulla cells [55] . Also, calcium and calmodulin activate ADAMTS1 expression [56] , a gene coding for a thrombospondin motif-containing metalloproteinase, up-regulated in treated blastocysts. Up-regulation of vimentin was also observed and appears to occur in diabetic nephropathy [57] . Vimentin is an important structural protein of intermediate filaments that exhibits organizational changes following various stimuli and transient association with PKC [58] . Hyperglycemia would disrupt cytoskeletal organization and affects mitochondrial distribution [15] as well as calcium signaling [59] .
The unified cause of all diabetic complications originates from hyperglycemia-induced uncoupling of OX-PHOS, which induces mitochondrial ROS production. Thereafter, ROS inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity and diverts glycolytic metabolites, which stimulate the polyol, AGE, PKC, and hexosamine pathways [36, 60, 61] . Collectively, these changes suggest that gene expression associated with diabetes in treated blastocysts may result from GAPDH inhibition by mitochondrial ROS produced during the period of hyperglycemia. It is consistent with experiments showing that porcine embryos cultured with elevated glucose exhibit a rise in ROS generation at the one-cell stage [62] . Moreover, decreased GAPDH activity was observed in embryos from diabetic rats or embryos cultured in hyperglycemia conditions [63] .
Associated with increased ROS production, uncoupling of OX-PHOS alters tricarboxylic acid cycle (TCA) activity in diabetes-associated hyperglycemia [64] . High-glucose-treated blastocysts showed a lower expression of citrate synthase, an enzyme involved in the entry of pyruvate-derived acetyl-CoA towards TCA and production of NADH for OX-PHOS. Decreased activity of citrate synthase is correlated with the pathology of diabetes and the potential dysregulation of mitochondrial oxidative capacity [65] . Decreased TCA activity in treated blastocysts may also be reflected by up-regulation of PPARG, a key regulator of lipid metabolism [66] . Preimplantation embryos undergo lipid oxidation [67] , which depends on TCA activity in mitochondria [68] . IVC bovine embryos show altered lipid metabolism, as seen by the lipid accumulation in embryonic cells [69] and overexpression of PPARG (Vigneault, Dufort, and Sirard, unpublished results). Dysregulation of mitochondrial TCA may induce lipid accumulation and PPARG expression in treated blastocysts [70] . In addition, lipid accumulation and oxidative stress due to mitochondrial dysfunction may be the rationale of higher expression of OLR1 in treated blastocysts [71] [72] [73] . OLR1 (oxidized lowdensity lipoprotein receptor 1) is a receptor involved in the scavenging of oxidized lipids and is up-regulated in diabetes [74, 75] , in preeclampsia [76] and during cell culture under CAGNONE ET AL.
high-glucose conditions [77] . Also, oxidized lipid accumulation may be responsible for the up-regulation of TNFRSF1A [78, 79] and C1QTNF3 [80] , which are associated with adipose tissues inflammation in diabetes.
Postcompaction development and hatching are energy demanding and correlate with increased mitochondrial OX-PHOS [81] , activation of glycolysis, and increased glucose uptake, which contribute to ATP synthesis [17] . Treated blastocysts show increased expression of LDHA, a gene coding for the main enzyme of anaerobic conversion of pyruvate into lactate, which produces NADþ and stimulates glycolysis. Moreover, PDGFC and HIF1A are also up-regulated. These two gene products contribute to the expression of LDHA [82] and promote anaerobic glycolysis in tumor cells [83, 84] , a phenomenon identified by Otto Warburg in 1924 [85] . The ''Warburg effect'' describes the metabolic shift observed during tumorigenesis when malignant cells increase glucose metabolism toward production of lactate rather than through mitochondrial OX-PHOS [86] . Transketolase 1, a gene coding an enzyme that catalyzes the nonoxidative part of the pentose phosphate pathway, was up-regulated in treated blastocysts. This enzyme is expressed in tumor cells in order to enhance glucose usage and lactate production [87] , and is known to be associated with the Warburg effect [88] [89] [90] .
The observed HIF1A up-regulation and the associated Warburg effect [91] [92] [93] [94] may result from mitochondria failing to perform OX-PHOS in treated embryos. Stimulation of HIF1A transcription may be mediated by overproduction of ROS and subsequent activation of PIK3-AKT/PKC/histone deacetylase pathways [95] . Moreover, hyperglycemia is correlated with defects in mitochondria biogenesis in diabetes [64, 96, 97] and mitochondria maturation is influenced by IVC during preimplantation development growth [98] . Perturbed mitochondria maturation would participate in Warburg effect induction in treated blastocysts.
Diabetic hyperglycemia is often associated with cancer predisposition [99, 100] and may be a driving force for the metabolic shift observed in treated blastocysts [101] . However, even if embryonic cells could adapt their metabolism through a common mechanism with cancer cells, it is likely that, at some point, early development would avoid a tumor fate. Treated blastocysts show up-regulation of IGFPB7 and TP53BP2, genes that are known to act as tumor suppressors [102] . TP53BP2 and p53 have synthetic action in regulating energy metabolism in cancer cells [103] . TP53BP2 mediates apoptosis associated with mitochondria death pathway and depression of the mitochondrial transmembrane potential [104] . Moreover, TP53 regulates the IGF1/MTOR pathway and controls IGFBP7 expression [105] . As hyperglycemia induces apoptosis through TRP53 signaling in mouse blastocysts [106] , the establishment of a tumor-like metabolism associated with the Warburg effect may activate TP53BP2 and IGFBP7 in order to drive embryonic cell death and compromise the development of treated blastocysts. This hypothesis is reinforced by the correlation between early embryonic lactate production and gestational demise in mouse [107] and human [108] .
In conclusion, we show here the detrimental impact of early hyperglycaemic stress on subsequent preattachment embryo survival and its association with differential gene expression at blastocyst stage. Functional analysis suggests that high glucose exposure during early cleavage stages increases ROS production (Fig. 4IIb) , a hypothesis that would imperatively require molecular analysis at earlier stages in the embryo development. However, gene expression associated with diabetes reveals altered glucose utilization during postcompaction development of treated embryos (Fig. 4II, c and d) . Accordingly, the embryonic response would be an increase of anaerobic glycolysis (Warburg effect) to compensate impairment of energy metabolism as well as limit ROS generation [109] , although this metabolic alternative would be inefficient to support proper blastocyst development and subsequent gestation [107, 110, 111] .
Taken together, these results shed new light on how the environment affects early embryo development. In order to complement these findings, overlapping the present results with other stress conditions would allow estimating the potential contribution of mitochondrial dysfunction in the developmental impairment of hyperglycemia-treated embryos. Nevertheless, these functional genomic analyses are now providing original insights for the development of stress marker examination in IVC embryos and eventually the design of optimized culture conditions in animal and human ART.
